Farmaprojects has its own GMP-certified laboratory at the Barcelona Science Park (PCB) for the import and release of medicines in the European Union (EU).

Thanks to this accreditation, granted by the Spanish Agency for Medicines and Health Products (Aemps, for its acronym), Farmaprojects offers high-quality analytical services at this center for pharmaceutical companies that require it, such as physicochemical analysis of medicines in all their pharmaceutical forms, drug stability studies and analytical method validations, among others.

This authorization allows to analyse and release medicines for human use within the European framework. Those companies that manufacture drugs outside the EU can contract the analysis service and its subsequent release for sale in any EU country.

This laboratory at the PCB has state-of-the-art equipment and highly qualified scientific and technical personnel who accompany and advise pharmaceutical laboratories around the world in these activities.

With more than three decades of experience in external licensing models and regulatory affairs, Farmaprojects’ know-how is completed with the experience in manufacturing, product development and marketing of the Polpharma group, one of the world’s leading players in the generic market, in which it is integrated.

This allows it to offer a portfolio of quality B2B products and services: supply of active pharmaceutical ingredients, license dossiers with supply of finished product, contract manufacturing services, as well as full support in pharmaceutical registration and intellectual property, among others.